Biote to purchase asteria health

Irving, texas--(business wire)--biote corp. (nasdaq: btmd) (“biote” or the “company”), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced a definitive agreement to acquire f.h. investments, inc., d/b/a asteria health, a privately held 503b manufacturer of compounded bioidentical hormones. the company operates an fda-registered 503b outsourcing facility in birmingham, alabama and currently sup.
BTMD Ratings Summary
BTMD Quant Ranking